Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8198601rdf:typepubmed:Citationlld:pubmed
pubmed-article:8198601lifeskim:mentionsumls-concept:C0521447lld:lifeskim
pubmed-article:8198601lifeskim:mentionsumls-concept:C0230664lld:lifeskim
pubmed-article:8198601lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8198601lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:8198601lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:8198601lifeskim:mentionsumls-concept:C0301818lld:lifeskim
pubmed-article:8198601pubmed:issue1lld:pubmed
pubmed-article:8198601pubmed:dateCreated1994-6-29lld:pubmed
pubmed-article:8198601pubmed:abstractTextThe steroid hormone 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3] stimulates biological responses via both genomic mechanisms and nongenomic mechanisms (opening of voltage-gated Ca2+ channels). We report here that the two closed B-ring steroid analogs of 1 alpha,25(OH)2D3, 1 alpha,25(OH)2-7-dehydrocholesterol and 1 alpha,25(OH)2-lumisterol3, are able to generate the nongenomic response, transcaltachia, without the ability to compete with the natural metabolite for binding to its nuclear receptor. We propose that the nongenomic membrane associated receptor can accept the ligand in its closed "6-s-cis" conformation whereas the nuclear receptor prefers the extended "6-s-trans" conformer.lld:pubmed
pubmed-article:8198601pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:languageenglld:pubmed
pubmed-article:8198601pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:citationSubsetIMlld:pubmed
pubmed-article:8198601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198601pubmed:statusMEDLINElld:pubmed
pubmed-article:8198601pubmed:monthMaylld:pubmed
pubmed-article:8198601pubmed:issn0006-291Xlld:pubmed
pubmed-article:8198601pubmed:authorpubmed-author:NormanA WAWlld:pubmed
pubmed-article:8198601pubmed:authorpubmed-author:OkamuraW HWHlld:pubmed
pubmed-article:8198601pubmed:authorpubmed-author:BishopJ EJElld:pubmed
pubmed-article:8198601pubmed:authorpubmed-author:NemereIIlld:pubmed
pubmed-article:8198601pubmed:authorpubmed-author:DormanenM CMClld:pubmed
pubmed-article:8198601pubmed:authorpubmed-author:HammondM WMWlld:pubmed
pubmed-article:8198601pubmed:issnTypePrintlld:pubmed
pubmed-article:8198601pubmed:day30lld:pubmed
pubmed-article:8198601pubmed:volume201lld:pubmed
pubmed-article:8198601pubmed:ownerNLMlld:pubmed
pubmed-article:8198601pubmed:authorsCompleteYlld:pubmed
pubmed-article:8198601pubmed:pagination394-401lld:pubmed
pubmed-article:8198601pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:meshHeadingpubmed-meshheading:8198601-...lld:pubmed
pubmed-article:8198601pubmed:year1994lld:pubmed
pubmed-article:8198601pubmed:articleTitleNonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors.lld:pubmed
pubmed-article:8198601pubmed:affiliationDepartment of Biochemistry, University of California, Riverside 92521.lld:pubmed
pubmed-article:8198601pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8198601pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8198601lld:pubmed